As part of the strategic realignment of its US business, the company has filed for voluntary liquidation under Chapter 7 of ...

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

A Financial District-based drug discovery company inked a $1 billion licensing agreement with pharmaceutical giant AbbVie to develop its signature cancer drug. IGI Therapeutics SA, a subsidiary of the ...

Hiding in Plain Sight Quantum computing has surged from theoretical curiosity to a transformative frontier, promising to ...

TandemAI, a company transforming drug discovery with state-of-the-art AI and physics-based technologies integrated with full wet lab capabilities, and Perpetual Medicines, which is advancing a ...

Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

Revolution Medicines has zeroed in on Iambic Therapeutics’ AI drug discovery platform, striking a multi-year technology and research collaboration that gives Iambic the chance to earn up to $25 mil | ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Multiple sclerosis (MS) is an immune-mediated inflammatory disease characterized by demyelination and degeneration in the ...

The Pacific Northwest National Laboratory has unveiled a new device that could transform drug testing, making it faster and more efficient.